| Reproductive Biology and Fertility | Lifetime | 37 | CN 1 | 99.76 |
| Ovarian function and disorders | Lifetime | 32 | CN 1 | 99.73 |
| Reproductive System and Pregnancy | Lifetime | 72 | CN 2 | 99.31 |
| Prenatal Screening and Diagnostics | Lifetime | 114 | CN 7 | 99.11 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 97 | CN 2 | 99.21 |
| Epigenetics and DNA Methylation | Lifetime | 968 | CN 93 | 97.91 |
| Sperm and Testicular Function | Lifetime | 503 | CN 13 | 97.96 |
| Reproductive Health and Technologies | Lifetime | 282 | CN 3 | 97.62 |
| Endometriosis Research and Treatment | Lifetime | 533 | CN 14 | 97.30 |
| Ovarian cancer diagnosis and treatment | Lifetime | 750 | CN 6 | 97.15 |
| Ectopic Pregnancy Diagnosis and Management | Lifetime | 224 | CN 7 | 97.06 |
| Renal and related cancers | Lifetime | 774 | CN 25 | 96.67 |
| Gynecological conditions and treatments | Lifetime | 254 | CN 5 | 96.88 |
| Lipid metabolism and disorders | Lifetime | 460 | CN 14 | 95.27 |
| Pluripotent Stem Cells Research | Lifetime | 997 | CN 82 | 95.11 |
| Demographic Trends and Gender Preferences | Lifetime | 346 | CN 14 | 91.91 |
| COVID-19 Impact on Reproduction | Lifetime | 785 | CN 28 | 87.74 |
| Reproductive Biology and Fertility | 2021-2025 | 1 | CN 1 | 99.94 |
| Ovarian function and disorders | 2021-2025 | 2 | CN 1 | 99.83 |
| Prenatal Screening and Diagnostics | 2021-2025 | 3 | CN 1 | 99.52 |
| Assisted Reproductive Technology and Twin Pregnancy | 2021-2025 | 12 | CN 2 | 98.94 |
| Reproductive System and Pregnancy | 2021-2025 | 27 | CN 12 | 98.39 |
| Epigenetics and DNA Methylation | 2021-2025 | 99 | CN 46 | 97.75 |
| Sperm and Testicular Function | 2021-2025 | 56 | CN 5 | 97.63 |
| Birth, Development, and Health | 2021-2025 | 244 | CN 28 | 95.89 |
| Renal and related cancers | 2021-2025 | 168 | CN 12 | 94.99 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 330 | CN 21 | 95.13 |
| Reproductive Health and Technologies | 2021-2025 | 205 | CN 7 | 92.22 |
| Gynecological conditions and treatments | 2021-2025 | 105 | CN 10 | 92.27 |
| RNA Research and Splicing | 2021-2025 | 774 | CN 218 | 88.54 |
| Biofuel production and bioconversion | 2021-2025 | 862 | CN 334 | 89.48 |
| Endometriosis Research and Treatment | 2021-2025 | 684 | CN 97 | 87.68 |
| Pluripotent Stem Cells Research | 2021-2025 | 445 | CN 80 | 85.05 |
| Demographic Trends and Gender Preferences | 2021-2025 | 73 | CN 6 | 83.83 |
| Enzyme Catalysis and Immobilization | 2021-2025 | 828 | CN 314 | 81.04 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 758 | CN 91 | 75.74 |
| Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities | 2021-2025 | 495 | CN 202 | 78.44 |
| Genetic Syndromes and Imprinting | 2021-2025 | 418 | CN 28 | 73.85 |
| Sexual Differentiation and Disorders | 2021-2025 | 802 | CN 53 | 69.55 |
| Ectopic Pregnancy Diagnosis and Management | 2021-2025 | 592 | CN 77 | 67.16 |
| Hypothalamic control of reproductive hormones | 2021-2025 | 745 | CN 103 | 47.47 |
| Sex and Gender in Healthcare | 2021-2025 | 678 | CN 12 | 43.67 |
